Jockey Club Seeks Tougher Equine Medication Rules
Tom LaMarra
March 30, 2012
Broad adoption of the new medication policies hinges on action by regulators in all racing jurisdictions.
Broad adoption of the new medication policies hinges on action by regulators in all racing jurisdictions.
In the wake of a March 25 New York Times report, Udall renewed his call for safety and integrity regulation.
Fourth edition of “World Rules for Equine Drug Testing and Therapeutic Medication Regulation” released.
Research indicates that combining NSAIDs achieved no better results than using either drug alone.
New 2012 code protocol deals with mainly with race-day medication model rules and race-day security.
The panel will provide insight on various health issues for the CHRB Medication and Track Safety Committee.
New York is returning to a standard banning the use of Bute in horses in the 48 hours leading up to a race.
One researcher concluded that when dosing PBZ in the horse, “More is not better. Less is less effective.”
Breeders’ Cup Ltd. upheld a ban on race-day medications for 2-year-olds at the 2012 World Championships.
The USEF and Equine Canada have implemented new regulations surrounding GABA and vedaprofen, respectively.
Clenbuterol use was suspended for Thoroughbred and Quarter Horse racing in New Mexicoeffective April 20.
The Life At Ten incident ultimately led to the implementation of new veterinary practices in racing.
The research pinpointed how long it took for some commonly used therapeutic drugs to clear a horse’s system.
A La., Senate committee rejected an emergency rule from the LSRC to lower the threshold to 2 micrograms/mL.
The trainer allegedly harassed a veterinarian and her assistant following a drug test on a horse last March.
The Equine Drug Research Council gave approval to changes in disciplinary measures for medication violations.
Stay on top of the most recent Horse Health news with
